Xolair 75 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FZS82
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,642
Award facts
- Contract value 100% obligated
- $4,642.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc. for the supply of XOLAIR 75 MG/0.5 ML syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of October 8, 2025, and represents a discrete fulfillment under the company's existing indefinite delivery contract vehicle with the Defense Logistics Agency.
This award exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. The company maintains a single-award indefinite delivery contract with the Defense Logistics Agency under the SPE2DB program valued at $499,999,999 through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facility operations. XOLAIR is a monoclonal antibody injection used primarily for treating moderate-to-severe allergic asthma and chronic idiopathic urticaria, indicating this order supports the pharmaceutical needs of Department of Defense healthcare facilities. DMS Pharmaceutical Group's contract history demonstrates consistent success in competing for federal pharmaceutical supply contracts across a diverse portfolio including branded and generic prescription drugs, biologics, and medical consumables.
Quick answers
Who was awarded contract SPE2DB25FZS82?
SPE2DB25FZS82 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FZS82 worth?
The government has obligated $4,642 on SPE2DB25FZS82.
Is contract SPE2DB25FZS82 an order under another contract?
Yes. SPE2DB25FZS82 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS82 competed?
The extent of competition for SPE2DB25FZS82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award